Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$14.00 – $14.00
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $66.73B | $70.39B | $81.61B | $86.95B | $91.42B | $95.54B | $103.75B | $111.39B |
| Cost of revenue | $46.12B | $48.44B | $55.68B | $61.41B | $62.97B | $66.29B | $72.44B | $77.72B |
| Gross profit | $20.62B | $21.95B | $25.93B | $25.54B | $28.45B | $29.25B | $31.32B | $33.68B |
| Gross margin | 30.9% | 31.2% | 31.8% | 29.4% | 31.1% | 30.6% | 30.2% | 30.2% |
| R&D | $40.0M | $27.0M | $28.0M | $17.0M | $25.0M | $0 | $0 | $0 |
| Operating income | $7.56B | $8.55B | $9.89B | $9.34B | $11.40B | $10.44B | $11.59B | $12.92B |
| EBITDA | $8.73B | $9.75B | $10.65B | $12.18B | $13.32B | $12.65B | $13.64B | $14.76B |
| Net income | $5.26B | $5.97B | $5.99B | $7.20B | $8.11B | $7.50B | $8.23B | $9.24B |
| Net margin | 7.9% | 8.5% | 7.3% | 8.3% | 8.9% | 7.9% | 7.9% | 8.3% |
| EPS (diluted) | 140.84 | 159.79 | 80.03 | 96.21 | 109.30 | 103.50 | 114.87 | 129.42 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2027 | $118.4B | $125.16 | $121.63–$128.63 | 1 |
| 2028 | $126.3B | $141.28 | $137.30–$145.20 | 1 |
| 2029 | $135.2B | $151.29 | $147.02–$155.48 | 1 |
| 2030 | $133.5B | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
AS ONE CORP ORD
No one on the platform currently holds IUSDF.
No tracked institution reports a position in IUSDF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2027-03-31 | $33.0000 | |
| 2026-09-30 | $33.0000 | |
| 2026-03-31 | $34.0000 | 2026-06-02 |
| 2025-09-30 | $31.0000 | 2025-12-02 |
| 2025-03-31 | $34.0000 | 2025-06-06 |
| 2024-09-30 | $28.0000 | 2024-12-03 |
| 2024-03-28 | $62.0000 | 2024-06-05 |
| 2023-09-29 | $50.0000 | 2023-12-04 |
| Execution date | Ratio |
|---|---|
| 2024-03-28 | 2-for-1 |
No one on the platform has traded IUSDF yet.
| $1.7B |
| — |
| PHMMFPharma Mar, S.A. | $79.49 | +0.00% | $1.4B | — |
| SAEYYRedcare Pharmacy N.V. | $7.55 | +0.00% | $1.5B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.